OSU6162 in the Treatment of Fatigue and Other Neuropsychological Sequelae After Aneurysmal Subarachnoid Hemorrhage - A Double-blind, Randomised, Placebo-controlled Study
Latest Information Update: 05 Nov 2021
At a glance
- Drugs OSU 6162 (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- 10 Nov 2019 Status changed from recruiting to completed.(2019-09-13)
- 03 Sep 2018 Status changed from not yet recruiting to recruiting.
- 11 Jul 2017 New trial record